SGLT2i in heart failure: Cardiorenal mechanisms, clinical evidence and translational perspectives
Overall, SGLT2i are a cornerstone of contemporary HF therapy, but further mechanistic, phenotype‐specific, and translational studies are required to optimize their clinical use and establish the safety and potential value of natural compounds as adjunctive strategies.